BR9910454A - Preparações efervescentes - Google Patents

Preparações efervescentes

Info

Publication number
BR9910454A
BR9910454A BR9910454-7A BR9910454A BR9910454A BR 9910454 A BR9910454 A BR 9910454A BR 9910454 A BR9910454 A BR 9910454A BR 9910454 A BR9910454 A BR 9910454A
Authority
BR
Brazil
Prior art keywords
effervescent preparations
sugar
preparations
meltable
effervescent
Prior art date
Application number
BR9910454-7A
Other languages
English (en)
Portuguese (pt)
Inventor
Reinharad Walter
Petra Ohage-Spitzlei
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of BR9910454A publication Critical patent/BR9910454A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/12—Mucolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Anesthesiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Oncology (AREA)
  • Nutrition Science (AREA)
  • Endocrinology (AREA)
  • Communicable Diseases (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
BR9910454-7A 1998-05-15 1999-05-03 Preparações efervescentes BR9910454A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19822036A DE19822036A1 (de) 1998-05-15 1998-05-15 Brausezubereitungen
PCT/EP1999/002969 WO1999059553A1 (de) 1998-05-15 1999-05-03 Brausezubereitungen

Publications (1)

Publication Number Publication Date
BR9910454A true BR9910454A (pt) 2001-01-02

Family

ID=7868010

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9910454-7A BR9910454A (pt) 1998-05-15 1999-05-03 Preparações efervescentes

Country Status (30)

Country Link
EP (1) EP1077684B1 (enExample)
JP (1) JP4452403B2 (enExample)
KR (1) KR100629817B1 (enExample)
AR (1) AR016473A1 (enExample)
AT (1) ATE246494T1 (enExample)
AU (1) AU3929799A (enExample)
BR (1) BR9910454A (enExample)
CA (1) CA2331671C (enExample)
CO (1) CO4830457A1 (enExample)
CZ (1) CZ300778B6 (enExample)
DE (2) DE19822036A1 (enExample)
DK (1) DK1077684T3 (enExample)
EE (1) EE04701B1 (enExample)
ES (1) ES2203134T3 (enExample)
GT (1) GT199900062A (enExample)
HN (1) HN1999000067A (enExample)
HR (1) HRP20000781B1 (enExample)
HU (1) HU224034B1 (enExample)
ID (1) ID27441A (enExample)
IL (1) IL139240A (enExample)
NO (1) NO20005722L (enExample)
PA (1) PA8472001A1 (enExample)
PE (1) PE20000465A1 (enExample)
PL (1) PL194347B1 (enExample)
PT (1) PT1077684E (enExample)
SI (1) SI1077684T1 (enExample)
SK (1) SK284621B6 (enExample)
TR (1) TR200003357T2 (enExample)
UY (1) UY25510A1 (enExample)
WO (1) WO1999059553A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6649186B1 (en) * 1996-09-20 2003-11-18 Ethypharm Effervescent granules and methods for their preparation
ATE258046T1 (de) * 1999-02-11 2004-02-15 Hexal Ag Pharmazeutische, metamizol enthaltende brauseformulierung
FR2823668B1 (fr) * 2001-04-20 2004-02-27 Ethypharm Lab Prod Ethiques Comprimes effervescents orodispersibles
DE602006001295D1 (de) * 2005-02-03 2008-07-03 Nycomed Pharma As Schmelzgranulation einer zusammensetzung mit einer calziumhaltigen verbindung
GR1007299B (el) * 2010-03-24 2011-06-06 Uni - Pharma Κλεων Τσετης Φαρμακευτικα Εργαστηρια Αβεε Με Δ.Τ. Uni-Pharma Αβεε, Πρωτοτυπη αναβραζουσα φαρμακευτικη συνθεση υδροχλωρικης μετφορμινης με τη μορφη δισκιου
WO2013022410A2 (en) 2011-08-08 2013-02-14 Mahmut Bilgic Production method for effervescent formulations comprising dexketoprofen
WO2016042372A1 (en) 2014-09-17 2016-03-24 Steer Engineering Private Limited Effervescent composition and method of making it
WO2017011326A1 (en) * 2015-07-10 2017-01-19 Sanjay Gupta Nasal foam via cribriform plate for medication delivery to the brain and/or body and for nasal moisturization and hygiene
US11219594B2 (en) * 2015-12-12 2022-01-11 Steerlife India Private Limited Effervescent compositions of metformin and processes for preparation thereof
JP2018183067A (ja) * 2017-04-24 2018-11-22 株式会社松原製餡所 発泡性添加物、及び、餡食品
EP4045008A4 (en) * 2019-10-17 2023-11-15 ISP Investments LLC A stable effervescent co-processed excipient composition and a process for preparing the same

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4004036A (en) * 1966-05-31 1977-01-18 Alberto Culver Company Effervescent molded triturate tablets
US3653914A (en) * 1970-03-20 1972-04-04 Alberto Culver Co Production of tablets
ATE108649T1 (de) * 1990-02-14 1994-08-15 Takeda Chemical Industries Ltd Brausemischung, deren herstellung sowie verwendung.
RU2096955C1 (ru) * 1991-03-01 1997-11-27 Е.И.Дюпон Де Немур Энд Компани Вододиспергируемая гранулированная пестицидная композиция, получаемая методом экструзии, и способ ее получения
MX9300110A (es) * 1992-01-13 1994-07-29 Gerhard Gergely Preparacion farmaceutica en la forma de una tableta de efervescencia o de desintegracion o de un granulado de tipo instanteneo y procedimiento para su preparacion.
HU217125B (hu) * 1993-03-10 1999-11-29 Béres Rt. Cukor- és nátriummentes pezsgőtabletta és -granulátum és eljárás azok előállítására
ATE173614T1 (de) * 1993-09-09 1998-12-15 Gerhard Gergely Brausegranulat und verfahren zu seiner herstellung
GB2307857B (en) * 1995-12-04 1999-01-27 Euro Celtique Sa An effervescent formulation

Also Published As

Publication number Publication date
CO4830457A1 (es) 1999-08-30
SK17062000A3 (sk) 2001-04-09
EE04701B1 (et) 2006-10-16
AU3929799A (en) 1999-12-06
NO20005722L (no) 2001-01-15
DK1077684T3 (da) 2003-11-17
CA2331671A1 (en) 1999-11-25
HUP0101822A3 (en) 2002-12-28
DE19822036A1 (de) 1999-11-18
KR100629817B1 (ko) 2006-09-29
CZ300778B6 (cs) 2009-08-12
JP2002515422A (ja) 2002-05-28
SI1077684T1 (en) 2003-12-31
AR016473A1 (es) 2001-07-04
PL344140A1 (en) 2001-10-08
HN1999000067A (es) 1999-09-29
DE59906519D1 (de) 2003-09-11
NO20005722D0 (no) 2000-11-13
PA8472001A1 (es) 2000-09-29
CA2331671C (en) 2008-01-08
HRP20000781A2 (en) 2001-06-30
TR200003357T2 (tr) 2001-05-21
IL139240A (en) 2005-08-31
JP4452403B2 (ja) 2010-04-21
EP1077684A1 (de) 2001-02-28
PE20000465A1 (es) 2000-07-07
EP1077684B1 (de) 2003-08-06
SK284621B6 (sk) 2005-07-01
UY25510A1 (es) 1999-12-13
PT1077684E (pt) 2003-12-31
PL194347B1 (pl) 2007-05-31
CZ20004171A3 (cs) 2001-03-14
WO1999059553A1 (de) 1999-11-25
EE200000650A (et) 2002-04-15
GT199900062A (es) 2000-10-20
ES2203134T3 (es) 2004-04-01
ID27441A (id) 2001-04-12
KR20010043600A (ko) 2001-05-25
HUP0101822A2 (hu) 2002-03-28
ATE246494T1 (de) 2003-08-15
HU224034B1 (hu) 2005-05-30
IL139240A0 (en) 2001-11-25
HRP20000781B1 (hr) 2010-06-30

Similar Documents

Publication Publication Date Title
MA26548A1 (fr) Compositions pharmaceutiques topiques contenant des derives de resorcinol.
EP0960621A3 (en) Pharmaceutical formulations comprising sildenafil
DZ2979A1 (fr) Composés nouveaux modulateurs de chimiokine ccr5, et compositions pharmaceutiques les contenant.
IL159086A0 (en) 3-aryl-5-aryl- [1, 2, 4] -oxadiazole derivatives and pharmaceutical compositions containing the same
DZ2887A1 (fr) Dérivés d'azétidine, leur préparation et les médicaments les contenant.
ZA988585B (en) Pharmaceutical compositions containing plasma protein.
ZA985364B (en) Pharmaceutical formulations containing voriconazole.
ZA200206905B (en) Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same.
MA26715A1 (fr) Composes chimiques nouveaux modulateurs de ccr5, et compositions pharmaceutiques les contenant.
HK1042444A1 (zh) 藥用噴霧製劑
AU7706698A (en) Mild, rinse-off antimicrobial liquid cleansing compositions containing salicylicacid
DZ2516A1 (fr) Composition pharmaceutique en aérosol.
NO954320L (no) Lyosfærer omfattende gonadotropin
HUP0000762A3 (en) 2-amino-6-(2-substituted-4-phenoxy)-substituted-pyridines, and pharmaceutical compositions containing them
AU2002333373A1 (en) Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof
AU683787B2 (en) Aromatic heterocyclic compounds, pharmaceutical and cosmetic compositions containing them and uses thereof
HUP0002853A3 (en) 6,7-asymmetrically disubstituted quinoxalinecarboxylic acid derivatives, and pharmaceutical compositions containing them
ZA9811445B (en) Aminobiguanides and the use thereof to disinfect contact lenses and preserve pharmaceutical compositions.
ZA200007415B (en) Amino acid derivatives and drugs containing the same as the active ingredient.
SE9802937D0 (sv) Novel compounds
WO2000076528A3 (de) Proteinenthaltende pharmazeutische zubereitung
PT996462E (pt) Preparados de combinacoes farmaceuticas contendo eritropoietina e hemoglobinas modificadas
AU7934298A (en) Novel nitroxyl compounds and drugs and reagents containing the same as the active ingredient
CA2331671A1 (en) Effervescent preparations
BR9605046B1 (pt) compostos n-(pirimidinl)-benzenossulfonamida e preparação farmacêutica contendo as mesmas.

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: BAYER HEALTHCARE AG (DE)

Free format text: TRANSFERIDO DE: BAYER AKTIENGESELLSCHAFT

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DA INT.CL: A61K 9/46, A61K 31/137, A61K 31/198, A61K 31/426, A61K 31/4402, A61K 45/00, A61K 47/02, A61K 47/10, A61K 47/12, A61K 47/26, A61P 1/04, A61P 1/08, A61P 1/10, A61P 3/02, A61P 3/ 06, A61P 3/10, A61P 9/02, A61P 11/06, A61P 11/12, A61P 11/14, A61P 23/02, A61P 25/00, A61P 25/02, A61P 25/04, A61P 25/08, A61P 31/04, A61P 37/00, A61P 43/00

Ipc: A61K 9/46 (2009.01)

B25A Requested transfer of rights approved

Owner name: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE)

Free format text: TRANSFERIDO POR FUSAO DE: BAYER HEALTHCARE AG

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 12A E 13A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2159 DE 22/05/2012.